EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced that the company will present at the NewsMakers in the Biotech Industry conference at 2:30 PM EDT, Friday, September 26, at the Millennium Broadway Hotel in New York City. Amit Munshi, President and CEO of EPIRUS, will present the company’s recent developments, including the approval in India of BOW015; business model; and pipeline.
Help employers find you! Check out all the jobs and post your resume.
